This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Tufts University, Janssen Biotech, Inc.. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brighton, MA (US) (2017)
- Boston, MA (US) (2020)
Company Filing History:
3 out of 655 
2 out of 433 
Years Active: 2017-2024
Title: The Innovative Contributions of Xun Ma
Introduction
Xun Ma is a notable inventor based in Boston, MA, who has made significant contributions to the field of medicine. He holds three patents, showcasing his dedication to advancing healthcare solutions. His work primarily focuses on the treatment of light chain amyloidosis and other hematological malignancies.
Latest Patents
Xun Ma's latest patents include innovative methods involving anti-CD38 antibodies for the treatment of light chain amyloidosis and other CD38-positive hematological malignancies. These inventions aim to provide effective therapeutic options for patients suffering from these serious conditions.
Career Highlights
Throughout his career, Xun Ma has worked with esteemed organizations such as Tufts Medical Center, Inc. and Janssen Biotech, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Xun Ma's notable coworkers include Raymond Comenzo and Chakra Chaulagain. Their collaborative efforts have further enhanced the impact of his inventions in the medical community.
Conclusion
Xun Ma's innovative work and patents reflect his commitment to improving treatment options for patients with hematological malignancies. His contributions are vital in the ongoing pursuit of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile